A Cohort Study on Drug A Use and Medication-Induced Dermatitis: Investigating Gender-Specific Associations and Risk

This cohort study investigates the association between the use of drug A and medication-induced dermatitis. The study aims to:

(1) Calculate the association separately by gender as a confounding factor. This step will help determine if the association between drug A use and medication-induced dermatitis differs between males and females.

(2) Develop a plan to test the hypothesis that females who use drug A have a higher risk of developing the disease than non-users. This plan will likely involve comparing the incidence of medication-induced dermatitis in female drug A users to the incidence in female non-users, adjusting for relevant covariates.

This study utilizes a cohort design, which involves following a group of individuals over time to assess the development of medication-induced dermatitis in relation to drug A use. By carefully controlling for gender and other potential confounding factors, the study aims to provide valuable insights into the relationship between drug A use and the risk of developing medication-induced dermatitis.